-- 
Roche Seeks FDA Approval for Skin Cancer Drug, Frings Says

-- B y   N a o m i   K r e s g e
-- 
2011-09-12T10:59:40Z

-- http://www.bloomberg.com/news/2011-09-12/roche-seeks-fda-approval-for-skin-cancer-drug-frings-says.html
Roche Holding AG (ROG)  has sought U.S.
Food and Drug Administration approval for an experimental drug
to treat a form of skin cancer, the companyâ€™s oncology head
said.  The filing for vismodegib to treat advanced basal cell
carcinoma was based on a study to be presented at the European
Multidisciplinary Cancer Congress next week, Stefan Frings said
in an interview today at Roche headquarters in Basel,
Switzerland. Roche is developing the drug with Lexington,
Massachusetts-based  Curis Inc. (CRIS)   To contact the reporter on this story:
Naomi Kresge in Basel, Switzerland, via 
 nkresge@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at   pserafino@bloomberg.net . 